SPY330.85+4.19 1.28%
DIA267.30+1.82 0.69%
IXIC11,197.96+193.09 1.75%

Raymond James Maintains Strong Buy on Blueprint Medicines, Raises Price Target to $122

Raymond James maintains Blueprint Medicines (NASDAQ:BPMC) with a Strong Buy and raises the price target from $106 to $122.

· 10/16/2020 07:27
Raymond James maintains Blueprint Medicines (NASDAQ:BPMC) with a Strong Buy and raises the price target from $106 to $122.